Cambridge Cognition Holdings Plc (GB:COG)
LSE:COG

Cambridge Cognition Holdings (COG) Share Price & Analysis

2 Followers

COG Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range91.50p - 145.00p
Previous Close100p
Volume5.48K
Average Volume (3M)43.98K
Market Cap
£34.70M
Enterprise Value2.61B
Total Cash (Recent Filing)£8.56M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)-83.1
Beta1.04
Sep 21, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding31,170,093
10 Day Avg. Volume43,665
30 Day Avg. Volume43,981
Standard Deviation0.20
R-Squared0.10
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-17032.84
Price to Sales (P/S)389.69
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

COG FAQ

What was Cambridge Cognition Holdings Plc’s price range in the past 12 months?
Cambridge Cognition Holdings Plc lowest share price was 91.50p and its highest was 145.00p in the past 12 months.
    What is Cambridge Cognition Holdings Plc’s market cap?
    Currently, no data Available
    When is Cambridge Cognition Holdings Plc’s upcoming earnings report date?
    Cambridge Cognition Holdings Plc’s upcoming earnings report date is Sep 21, 2023 which is in 108 days.
      How were Cambridge Cognition Holdings Plc’s earnings last quarter?
      Cambridge Cognition Holdings Plc released its earnings results on May 03, 2023. The company reported -0.014p earnings per share for the quarter, missing the consensus estimate of N/A by -0.014p.
        Is Cambridge Cognition Holdings Plc overvalued?
        According to Wall Street analysts Cambridge Cognition Holdings Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Cambridge Cognition Holdings Plc pay dividends?
          Cambridge Cognition Holdings Plc does not currently pay dividends.
          What is Cambridge Cognition Holdings Plc’s EPS estimate?
          Cambridge Cognition Holdings Plc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Cambridge Cognition Holdings Plc have?
          Cambridge Cognition Holdings Plc has 34,815,388 shares outstanding.
            What happened to Cambridge Cognition Holdings Plc’s price movement after its last earnings report?
            Cambridge Cognition Holdings Plc reported an EPS of -0.014p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.615%.
              Which hedge fund is a major shareholder of Cambridge Cognition Holdings Plc?
              Currently, no hedge funds are holding shares in GB:COG

              ---

              Cambridge Cognition Holdings Stock Smart Score

              1
              Underperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -26.19%
              12-Months-Change

              Fundamentals

              Return on Equity
              -112.52%
              Trailing 12-Months
              Asset Growth
              20.47%
              Trailing 12-Months
              The Cambridge Cognition Holdings Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Cambridge Cognition Holdings Plc

              Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the precise measurement of clinical outcomes in neurological disorders. The company product segments include Software, Services, and Hardware. It generates maximum revenue from the Software segment. Geographically, it derives majority revenue from the United States of America and also has a presence in the United Kingdom, European Union, and Rest of world. The company services include Neuroscience consultancy, Technical consultancy, Study design, Data analysis, Study management, Data management, and Reports and interpretation.

              ---

              Forecast EPS vs Actual EPS


              Similar Stocks
              Company
              Price & Change
              Follow
              Advanced Oncotherapy
              Tissue Regenix
              Induction Healthcare Group Plc

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis